Enteral and Parenteral Therapy Medicaid payments in Massachusetts rise 1.4% in 2024
In 2024, Massachusetts Medicaid providers billed $21,360,973 for Enteral and Parenteral Therapy services, reflecting a 1.4% increase from the prior year.

In 2024, Massachusetts Medicaid providers billed $21,360,973 for Enteral and Parenteral Therapy services, reflecting a 1.4% increase from the prior year.

Voting records show 208 House members opposed the Safeguard American Voter Eligibility Act, a measure aimed at tightening voter eligibility requirements.

Guido Andres Alexander Cuellar-Batres, a Guatemalan national, was sentenced to eight months in prison and one year of supervised release after pleading guilty to assaulting U.S. Immigration and Customs Enforcement (ICE) officers during an arrest…

The Beth Israel Deaconess Medical Center Institutional Review Board in Boston underwent an FDA bioresearch monitoring inspection on May 8, 2024, as detailed on the FDA’s website.

On July 8, 2024, the FDA conducted an inspection of The Alphas Company, Inc. in Chelsea focused on foodborne biological hazards, according to information published on the FDA’s website.

Jacob D. Soumerai, M.D., based in Boston, underwent an FDA inspection for bioresearch monitoring on January 26, 2024, according to information posted on the FDA’s website.

FDA records show an inspection at American Nut & Chocolate, Inc. in Boston on November 5, 2024, focusing on foodborne biological hazards.

FDA records show an inspection at Yell-O-Glow Corporation Chelsea in Chelsea on October 30, 2024, focusing on foodborne biological hazards.

On March 4, 2024, the FDA conducted an inspection of Golden Cannoli Shells Company, Inc. in Chelsea focusing on foodborne biological hazards, according to information available on the FDA’s website.

The FDA conducted a bioresearch monitoring inspection at Servier Pharmaceuticals, LLC. in Boston on March 5, 2024.